What is the Impact Factor of Technology in Cancer Research & Treatment?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Technology in Cancer Research & Treatment is 2.70, ranking in quartile Q3 of Web of Science (SCIE).

Is Technology in Cancer Research & Treatment indexed in Web of Science or Scopus?

Yes, Technology in Cancer Research & Treatment is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.674 (Q2) and an H-index of 78.

Who publishes Technology in Cancer Research & Treatment and what is the Article Processing Charge (APC)?

Technology in Cancer Research & Treatment is published by SAGE Publications Inc.. The estimated Article Processing Charge (APC) is approximately $3,065 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Technology in Cancer Research & Treatment?

The official ISO-4 abbreviation of Technology in Cancer Research & Treatment is "TECHNOL. CANCER RES. TREAT". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #8,627Hybrid

Technology in Cancer Research & Treatment

Abbreviation (ISO):TECHNOL. CANCER RES. TREAT

•

Identifier (ISSN):1533-0346(Print)/1533-0338(Online)

•

Publisher:SAGE Publications Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.7↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Technology in Cancer Research & Treatment

WoS Q3

Annual Impact Factor Metric

Current (2026):2.7

Scopus SJR & RankScopus Q2

0.674

#8,627

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

78 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate3.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

256articles/year

99.82% Gold OA•78.48% Original Research

Aims & Scope

Technology in Cancer Research & Treatment (TCRT) is a JCR-ranked, broad-spectrum, open access, peer-reviewed publication whose aim is to provide researchers and clinicians with a platform to share and discuss developments in the prevention, diagnosis, treatment, and monitoring of cancer.

Topics Covered (Recognized by AI)

Medicine96.9%Internal medicine87.4%Biology81.7%Genetics72.6%Surgery53.9%Cancer53%Chemistry52%Radiology50.3%Biochemistry43.5%Pathology43.5%Physics37.5%Cancer research33.9%Radiation therapy32.5%Gene31.6%Nuclear medicine31.6%Computer science26.2%Oncology26.1%Mathematics25.5%Immunology21%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank185/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank210/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	185/333	Q3
ONCOLOGY	JCISCIE	210/333	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.7

Articles / Year159

Total Citations53

2025

IF2.8

Articles / Year163

Total Citations422

2024

IF2.7

Articles / Year216

Total Citations1,169

2023

IF2.8

Articles / Year239

Total Citations2,244

2022

IF2.876

Articles / Year239

Total Citations2,681

Year	Impact Factor	Articles / Year	Total Citations
2026	2.7	159	53
2025	2.8	163	422
2024	2.7	216	1,169
2023	2.8	239	2,244
2022	2.876	239	2,681
2021	3.399	303	4,189
2020	2.074	320	5,056
2019	1.481	177	4,666
2018	1.646	167	4,498
2017	—	76	1,230
2016	—	80	1,563
2015	—	114	1,858

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,627Scopus Q2SCImago Profile

Scopus Coverage:2002-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.674

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.86

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,065 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,943

3-Year Documents666

Citable Documents651

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Cancer ResearchQ3

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Technology in Cancer Research & Treatment (abbr: TECHNOL. CANCER RES. TREAT, ISSN: 1533-0346) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Inc. in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.674 (Q2), an H-index of 78.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 256 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,065 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.